CRISPR THERAPEUTICS
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a revolutionary technology that allows for precise, directed changes to genomic DNA. They have licensed the foundational CRISPR/Cas9 patent estate for human therapeutic use from their scientific founder, Dr. Emmanuelle Charpentier, who co-invented the application of CRISPR/Cas9 for gene editing. CRISPR Therapeuticsโ vision is to cure serious human diseases at the molecular level using CRISPR-Cas9. The company is headquartered in Basel, Switzerland and has operations in London, UK.
CRISPR THERAPEUTICS
Industry:
Biopharma Biotechnology Genetics Medical
Founded:
2013-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.crisprtx.com
Total Employee:
101+
Status:
Active
Contact:
141794589327
Total Funding:
127 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Nginx Microsoft Exchange Online
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Stephen Kennedy Head Of Technical Operations @ CRISPR Therapeutics
Head Of Technical Operations
Daniel Anderson Scientific Founders @ CRISPR Therapeutics
Scientific Founders
Lawrence Klein Chief Operating Officer @ CRISPR Therapeutics
Chief Operating Officer
2016-01-01
Doug Treco Director @ CRISPR Therapeutics
Director
2019-03-01
Phuong Khanh Morrow chief medical officer @ CRISPR Therapeutics
chief medical officer
2022-05-01
Chris Gemmiti Executive Director of Technical Operations @ CRISPR Therapeutics
Executive Director of Technical Operations
2020-11-01
Emmanuelle Charpentier Co-Founder & Scientific Advisory Board Member @ CRISPR Therapeutics
Co-Founder & Scientific Advisory Board Member
Rodger Novak Co-Founder & President @ CRISPR Therapeutics
Co-Founder & President
2017-12-01
Craig Mello Scientific Founders @ CRISPR Therapeutics
Scientific Founders
Andrew Kernytsky Senior Director, Head of Genomics and Computational Biology @ CRISPR Therapeutics
Senior Director, Head of Genomics and Computational Biology
Founder
Stock Details
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - CRISPR Therapeutics
Wellington Capital Management
Wellington Capital Management investment in Series B - CRISPR Therapeutics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series B - CRISPR Therapeutics
Clough Capital Partners
Clough Capital Partners investment in Series B - CRISPR Therapeutics
Franklin Templeton Investments
Franklin Templeton Investments investment in Series B - CRISPR Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series B - CRISPR Therapeutics
Versant Ventures
Versant Ventures investment in Series B - CRISPR Therapeutics
SR One
SR One investment in Series B - CRISPR Therapeutics
Abingworth
Abingworth investment in Series B - CRISPR Therapeutics
Vertex Pharmaceuticals
Vertex Pharmaceuticals investment in Series B - CRISPR Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-05-17 | On a Roll, CRISPR TX Taps Amgen Veteran P.K. Morrow as New CMO |
2021-10-14 | CRISPR Therapeutics Announces Transition of Chief Financial Officer |
Official Site Inspections
http://www.crisprtx.com Semrush global rank: 315.99 K Semrush visits lastest month: 197.21 K
- Host name: 64.62.152.250
- IP address: 64.62.152.250
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago